BioLineRx (BLRX) Posts Q3 Loss of 1c/ADS
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.